Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 11-2012 | 09-2012 | |
| Cost of Goods | N/A | N/A | N/A | N/A | 8,236 |
| Gross Profit | N/A | N/A | N/A | N/A | -8,236 |
| Operating Expenses | 5,100 | 1,886 | 26,692 | 4 | 460 |
| Operating Income | -5,100 | -1,886 | -13,499 | -4 | -8,460 |
| Interest Expense | 0 | 0 | 14 | 0 | 27 |
| Other Income | 51 | -2,983 | -4,775 | 0 | 6 |
| Pre-tax Income | -5,049 | -4,869 | -18,288 | -4 | -8,481 |
| Net Income Continuous | -5,049 | -4,869 | -26,765 | -4 | -8,481 |
| Net Income | $-5,049 | $-4,869 | $-26,765 | $-4 | $-8,481 |
| EPS Basic Total Ops | -0.41 | -0.46 | -5.28 | -0.03 | -2.42 |
| EPS Basic Continuous Ops | -0.41 | -0.46 | -6.79 | -0.03 | -2.42 |
| EPS Diluted Total Ops | -0.41 | -0.46 | -6.68 | -0.03 | -2.42 |
| EPS Diluted Continuous Ops | -0.41 | -0.46 | -6.79 | -0.03 | -2.42 |
| EBITDA(a) | $-5,047 | $-1,833 | $-26,640 | $-4 | $-8,424 |